B

Boundless Bio
D

BOLD

1.06000
USD
-0.01
(-0.47%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
0
حجم السوق
23,728,748
المقالات

العنوان: Boundless Bio

القطاع: Healthcare
الصناعة: Biotechnology
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.